Agena Bioscience®新闻报道

最新新闻稿

  • Agena Bioscience and Diatech Pharmacogenetics Announce Plan to Launch Actionable, Targeted CE-IVD Marked Oncology Assays for Colon, Lung, and Melanoma Treatment More

    SAN DIEGO, Calif., Oct. 27, 2015 -- Agena Bioscience announced today the planned commercial launch of its CE-IVD marked MassARRAY®...

  • Agena Bioscience to Present Enabling Solutions for Molecular Blood Group Genotyping at AABB 2015 More

    SAN DIEGO, Calif., Oct. 20, 2015 -- Agena Bioscience™ today announced expanded use of its MassARRAY® System...

  • Agena Bioscience Opens Office in Shanghai, China More

    SAN DIEGO, Calif., Sep. 1, 2015 -- Agena Bioscience today announced the establishment of a subsidiary in Shanghai, a commercial...

  • Agena Bioscience Introduces Front-End Automation for Its MassARRAY® System for Genetic Analysis More

    New Chip Prep Module Streamlines Workflow and Reduces Hands-On Time for Laboratories Implementing Genetic TestingSAN DIEGO,...

  • Agena Bioscience European Distributors Expand to KAWA.SKA and BioGen-Analytica 更多

    SAN DIEGO, Calif., Jun. 11, 2015 -- Agena Bioscience today expanded its European distributors through new relationships with...

  • Agena Bioscience Names Bioyong Technology as Fifth Certified Service Provider in China More

    SAN DIEGO, Calif., Apr. 27, 2015 -- Agena Bioscience today announced Bioyong Technology as the fifth certified service provider...

  • Agena Bioscience Launches LungFUSION Panel for Rapid Identification of ALK, RET, and ROS1 Translocations in NSCLC Tumors More

    SAN DIEGO, March 25, 2015 /PRNewswire/ -- Agena Bioscience today released the LungFUSION Panel for rapid and sensitive identification...

  • Agena Bioscience Launches MassARRAY® 24-Well System for Affordable Genetic Testing, Liquid Biopsies More

    SAN DIEGO, Calif., Feb. 24, 2015 -- Agena Bioscience today released the MassARRAY® 24-Well System for mass spectrometry-based...

  • Agena Bioscience Appoints Peter Dansky as Chief Executive Officer More

    Life science industry executive to guide expansion of MassARRAY® platform into the clinical research and diagnostics...

  • Agena Bioscience Announces FDA 510(K) Premarket Clearance of the IMPACT Dx Factor V Leiden and Factor II Genotyping Test on the IMPACT Dx System More

    IMPACT Dx Combined Function System Will Also Be Available in the European UnionSan Diego, Calif., June 16,...

  • Agena Bioscience Introduces the Hemo ID Panel for Blood Group Genotyping at the 33rd International Congress of the ISBT in Seoul, Korea More

    Swiss Red Cross Study Recommends Replacing Kell, Kidd, Duffy Serotyping with GenotypingSan Diego, Calif., June 4, 2014/PRNewswire/...

  • Sequenom, Inc.’s Bioscience Business Acquired by Agena Bioscience, a Telegraph Hill Partners Portfolio Company More

    John Lillig to Lead Agena Bioscience as Chairman and Interim CEOSan Diego, Calif. – May 30, 2014 – Agena Bioscience,...